Metacrine, Inc.

ACTIVE

3985 Sorrento Valley Blvd Ste C, 加利福尼亚州圣迭戈县, California, United Stateswww.metacrine.comPublic32 employeesEstablished: 2015-01-01

Also known as:

Metacrine

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

50.0%

Phase 1

25.0%

Trial Status Distribution

Completed

75.0%

Unknown

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Study to Evaluate MET642 in Patients With NASH

Phase 2

Completed

interventional

Mar 2021215 participants

Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH

Phase 2

Unknown

interventional

Dec 2020120 participants

A study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of MET642 in healthy subjects.

Phase 1

Completed

interventional

Feb 202064 participants

A randomized, double-blind, placebo-controlled, safety, tolerability, pharmacokinetic, and pharmacodynamic study of MET409 after single and multiple ascending oral dose administration in healthy male subjects

Completed

interventional

124 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations